21st Austria weekly Marinomed 24042019

21st Austria weekly - Marinomed (24/04/2019)

07:22 EDT 28 Apr 2019 | FinanzNachrichten

Marinomed: Stock quoted biotech company Marinomed Biotech AG has announced the successful completion of the pivotal Phase III study for Budesolv. The top line results are now available and show tha...

Original Article: 21st Austria weekly - Marinomed (24/04/2019)

More From BioPortfolio on "21st Austria weekly - Marinomed (24/04/2019)"